Plasmodium vivax malaria serological exposure markers: Assessing the degree and implications of cross-reactivity with P. knowlesi

Rhea Longley (1, 2) , Matthew Grigg (3) , Kael Schoffer (1) , Thomas Obadia (4, 5) , Stephanie Hyslop (1) , Kim Piera (3) , Narimane Nekkab (5) , Ramin Mazhari (1, 2) , Eizo Takashima (6) , Takafumi Tsuboi (6) , Matthias Harbers (7) , Kevin Tetteh (8) , Chris Drakeley (8) , Chetan Chitnis (9) , Julie Healer (1, 2) , Wai-Hong Tham (1, 2) , Jetsumon Sattabongkot (10) , Michael White (5) , Daniel Cooper (3, 11) , Giri Rajahram (12) , Bridget Barber (3) , Timothy William (13) , Nicholas Anstey (14) , Ivo Mueller (1, 2)

1 WEHI - The Walter and Eliza Hall Institute of Medical Research
2 University of Melbourne
3 Charles Darwin University [Australia]
4 Hub Bioinformatique et Biostatistique - Bioinformatics and Biostatistics HUB
5 Epidémiologie et Analyse des Maladies Infectieuses - Infectious Disease Epidemiology and Analytics
6 Ehime University [Matsuyama, Japon]
7 RIKEN IMS - RIKEN Center for Integrative Medical Sciences [Yokohama]
8 LSHTM - London School of Hygiene and Tropical Medicine
9 Biologie de Plasmodium et Vaccins - Malaria Parasite Biology and Vaccines
10 Mahidol University [Bangkok]
11 CAM - University of Cambridge [UK]
12 Hospital Queen Elizabeth II [Kota Kinabalu, Sabah, Malaysia]
13 Infectious Diseases Society Kota Kinabalu Sabah [Malaysia]
14 Gleneagles Hospital [Kota Kinabalu, Sabah, Malaysia]

Domaines: Santé publique et épidémiologie

Rhea Longley, Matthew Grigg, Kael Schoffer, Thomas Obadia, Stephanie Hyslop, et al.. Plasmodium vivax malaria serological exposure markers: Assessing the degree and implications of cross-reactivity with P. knowlesi. Cell Reports Medicine, 2022, 3 (6), pp.100662. ⟨10.1016/j.xcrm.2022.100662⟩. ⟨pasteur-03709034⟩